Two more things to know:
1. The Senate version of the bill’s biggest targets are to require drugmakers to pay Medicare if the drug’s price rises faster than inflation rates, which would begin in 2023, and to allow the HHS to negotiate prices for drugs, which would take effect in 2026.
2. Another tenet of the legislation is limiting the copay for Medicare and Medicaid recipients, which is expected to pass into law, according to CNN.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
